Jeffrey Dierks, CHIEF COMMERCIAL OFFICER at Harmony Biosciences Holdings, Inc. (HRMY), sold 400 shares at $40.19 ($16K) on 2024-10-01, disclosed to the SEC on 2024-10-02.
Scheduled sale ($16k) by CHIEF COMMERCIAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| HRMY | SELL | 2025-01-21 | $2.3M | — | Filing → |
| HRMY | SELL | 2025-01-16 | $778K | — | Filing → |
| HRMY | SELL | 2025-01-15 | $532K | — | Filing → |